AstraZeneca hikes forecasts amid Pfizer bid fallout
July 31, 2014 at 02:25 AM EDT
AstraZeneca claimed to have "one of the most exciting pipelines" in the pharmaceutical industry, as it reported a second-quarter revenue rise.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.